Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-21.56%
↓ 82% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-11.84%
Historical baseline
PeriodValue
2024-21.56%
202312.98%
2022-21.24%
2021-36.84%
202054.19%
2019-75.73%
2018-16.41%
201768.37%
2016-15.86%
2015-66.25%